News & Articles

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

At ESCMID Global 2026, Bruker announced important portfolio enhancements across microbial identification, outbreak analysis, and reflex next‑generation sequencing (NGS) typing

In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1

Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy

Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026

Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free

Vote for the products that have made the most difference to your research for the chance to win a $100 Amazon Gift Card (or equivalent currency)

Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies

Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets

Expanded CFTR variant coverage designed to align with updated professional recommendations

After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories

Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck

Discover how BRANDTECH’s latest pipette allows temporary fine-tuning for different liquids, temperatures, and tip styles

The U.S. FDA has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH)

Equipped with the READY System to make structural biology research accessible to more labs

Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing

See how Honeywell and METTLER TOLEDO collaborated to unlock new frontiers for Hydranal reagent formulation via automated titration

Advancing efficiency and uptime in gas chromatography

Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial

How Roche and Disease Management Consulting empower laboratory professionals to drive strategic value in healthcare systems

The treatment preserved quality of life

Showcased at AACR 2026 with data from leading research institutions, including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ)

From spreadsheet silos to AI-powered insights, discover how Signals software is streamlining formulation science

IDE approval by the FDA expands global trial to the United States as first study participant is treated in the United Kingdom